Theoretical Cost-Effectiveness of PCSK9 Inhibitors in Stroke Due to Intracranial Atherosclerosis - Top-Institutions - MDSpire

Theoretical Cost-Effectiveness of PCSK9 Inhibitors in Stroke Due to Intracranial Atherosclerosis

  • By

  • Caroline Kellogg

  • Elena Badillo Goicoechea

  • David D. Kim

  • Shadi Yaghi

  • Seemant Chaturvedi

  • Rachel Mehendale

  • Karen Orjuela

  • Tareq Kass-Hout

  • Rami Z. Morsi

  • Jacqueline Morales

  • Eesha Singh

  • Aditya Jhaveri

  • Shyam Prabhakaran

  • Matthew M. Smith

  • James R. Brorson

  • Samiksha Golani

  • Sofia Mazuera

  • Rachael Kang

  • Ali Eltatawy

  • Jessica Pillajo

  • James E. Siegler

  • May 5, 2026

  • 0 min

Share

Top Institutions in Urology

Brief introduction explaining scope and methodology.

  • #1

    National Institute of Neurological Disorders and Stroke
    National Institute of Neurological Disorders and Stroke

    Bethesda, MD

    Key Differentiators

    • Neurology

  • #2

    National Institutes of Health
    National Institutes of Health

    Bethesda, MD

    Key Differentiators

    • Neurology
    • Public Health

  • #3

    University of California Health Data Warehouse
    University of California Health Data Warehouse

    Sacramento, CA

    Key Differentiators

    • Neurology
    • Data Science

  • #4

    Northwestern University Feinberg School of Medicine
    Northwestern University Feinberg School of Medicine

    Chicago, IL

    Key Differentiators

    • Neurology
    • Medicine

  • #5

    Swedish Heart Failure Registry
    Swedish Heart Failure Registry

    Stockholm, SE

    Key Differentiators

    • Cardiology
    • Neurology

Original Source(s)

Theoretical Cost-Effectiveness of PCSK9 Inhibitors in Stroke Due to Intracranial Atherosclerosis

  • by Caroline Kellogg, Elena Badillo Goicoechea, David D. Kim, Shadi Yaghi, Seemant Chaturvedi, Rachel Mehendale, Karen Orjuela, Tareq Kass-Hout, Rami Z. Morsi, Jacqueline Morales, Eesha Singh, Aditya Jhaveri, Shyam Prabhakaran, Matthew M. Smith, James R. Brorson, Samiksha Golani, Sofia Mazuera, Rachael Kang, Ali Eltatawy, Jessica Pillajo, James E. Siegler

  • May 5, 2026

Related Content

Marcus Neuroscience Institute to Host 2026 Brain & Spine Symposium

Marcus Neuroscience Institute, part of Baptist Health South Florida, will host its two-day 2026 Brain & Spine Symposium on May 14 and 15.

  • by

  • April 6, 2026

  • 3 min
Efficacy and safety of tirofiban for acute ischemic stroke without large and medium vessel occlusion: a systematic review and meta-analysis

Assessing the Effectiveness of the RACE Score in Distinguishing Stroke from Stroke Mimics in Emergency Department Settings